Cargando…
Exploration of 2D and 3D-QSAR analysis and docking studies for novel dihydropteridone derivatives as promising therapeutic agents targeting glioblastoma
Background: Dihydropteridone derivatives represent a novel class of PLK1 inhibitors, exhibiting promising anticancer activity and potential as chemotherapeutic drugs for glioblastoma. Objective: The aim of this study is to develop 2D and 3D-QSAR models to validate the anticancer activity of dihydrop...
Autores principales: | Pan, Meichen, Cheng, Lingxue, Wang, Yiguo, Lyu, Chunyi, Hou, Chao, Zhang, Qiming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10501407/ https://www.ncbi.nlm.nih.gov/pubmed/37719847 http://dx.doi.org/10.3389/fphar.2023.1249041 |
Ejemplares similares
-
3D,2D-QSAR study and docking of novel quinazolines as potential target drugs for osteosarcoma
por: Lian, Zheng, et al.
Publicado: (2023) -
3D-QSAR, Molecular Docking, and MD Simulations of Anthraquinone Derivatives as PGAM1 Inhibitors
por: Wang, Yuwei, et al.
Publicado: (2021) -
2D, 3D-QSAR study and docking of vascular endothelial growth factor receptor 3 (VEGFR3) inhibitors for potential treatment of retinoblastoma
por: Ren, Rui, et al.
Publicado: (2023) -
3D-QSAR, docking and ADMET properties of aurone analogues as antimalarial agents
por: Hadni, Hanine, et al.
Publicado: (2020) -
QSAR and molecular docking studies on designing potent inhibitors of SARS-CoVs main protease
por: Song, Fucheng, et al.
Publicado: (2023)